A 80556
Alternative Names: A 65326 . HClLatest Information Update: 21 May 2001
At a glance
- Originator Abbott Laboratories
- Class Antibacterials; Fluoroquinolones
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 21 May 2001 Profile reviewed but no significant changes made
- 21 May 2001 No-Development-Reported for Bacterial infections in USA (Unknown route)